LawGrids logoLAWGRIDS.ORG

Section 25, The Assisted Reproductive Technology (Regulation) Act, 2021: Preimplantation Genetic Diagnosis

The Assisted Reproductive Technology (Regulation) Act, 2021 (42 of 2021) - Section 25

Text of section 25

Preimplantation Genetic Diagnosis.

(1) The Pre-implantation Genetic testing shall be used to screen the human embryo for known, pre-existing, heritable or genetic diseases only. (2) The donation of an embryo after Pre-implantation Genetic Diagnosis to an approved research laboratory for research purposes shall be done only-- (a) with the approval of the commissioning couple or woman; and (b) when the embryo suffers from pre-existing, heritable, life-threatening or genetic diseases. (3) The National Board may lay down such other conditions as it deems fit in the interests of the Pre-implantation Genetic testing. Explanation. --For the purposes of this section, the expression-- (i) "Pre-implantation Genetic Diagnosis" means the genetic diagnosis when one or both genetic parents has a known genetic abnormality and testing is performed on an embryo to determine if it also carries a genetic abnormality; and (ii) "Pre-implantation Genetic testing" means a technique used to identify genetic defects in embryos created through in-vitro fertilisation before pregnancy.

Previous and next

All sections of The Assisted Reproductive Technology (Regulation) Act, 2021

Questions people ask

Is section 25 of the Assisted Reproductive Technology (Regulation) Act, 2021 still in force?

No repeal of the Assisted Reproductive Technology (Regulation) Act, 2021 is recorded.